D2Q-33103-20928 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-31
Dose 1 — Pfizer-BioNTech
2021-04-21
Dose 2 — Pfizer-BioNTech
2021-11-08
Dose 3 — Moderna
2021-11-09
Registered in v-safe
2021-11-09
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-11-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache, Diarrhea

Adult check-in
2021-11-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-11-15
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-22
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-29
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-06
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-15
Survey response — day 35, dose 3
MedDRA: Diarrhoea, Pyrexia — Feeling: Good · Be unable to do your normal daily activities

Free text: Diarrhea, low grade fever

MedDRA releases: 2024-11 · check-in free text available
2021-12-22
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-05-11
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-10
Survey response — 12 months, dose 3
MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Runny nose, congestion

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-31	Pfizer-BioNTech	No
2	2021-04-21	Pfizer-BioNTech	No
3	2021-11-08	Moderna	No

Free text

Release 10 — day 35, dose 3

2021-12-15

Symptoms: Diarrhea, low grade fever

Release 12 — 12 months, dose 3

2022-11-10

Symptoms: Runny nose, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diarrhoea	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release